← Eichor
Condition: Pelvic Malignancies Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Pelvic Malignancies

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Pelvic Cancer Registry for Online Adapted Radiotherapy
Phase N/A · 1 location(s) · University Medical Center Goettingen · NCT06185062Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients
Phase N/A · 3 location(s) · University of California, San Diego · NCT05705219Surgical Treatment With or Without Apalutamide in Subjects With High Risk Prostate Cancer Who Are Candidates for Radical
Phase 2 · 1 location(s) · Marco Oderda · NCT06758882Early Prostate Cancer Recurrence With PSMA PET Positive Unilateral Pelvic Lesion(s)
NA · 1 location(s) · Martini-Klinik am UKE GmbH · NCT04271579Cohort of Patients With Pelvic Gynecological Cancer: Constitution of a Collection of Biological Samples With Radioclinic
Phase N/A · 2 location(s) · Centre Hospitalier Intercommunal Creteil · NCT03622983FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3
Phase 1 · 82 location(s) · Eli Lilly and Company · NCT05614739Dutch National Randomized Study: PSMA-PET/CT As a Triage Tool for Pelvic Lymph Node Dissection in Prostatectomy Patients
NA · 1 location(s) · Canisius-Wilhelmina Hospital · NCT05000827Biofeedback-Assisted Pelvic Floor Rehabilitation for Radiation-Induced Sexual Dysfunction in Cervical Cancer Survivors
NA · 1 location(s) · Beni-Suef University · NCT075970839MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma
Phase 2 · 2 location(s) · Mabwell (Shanghai) Bioscience Co., Ltd. · NCT06823427Radiofrequency and Exercise-based Rehabilitation on Symptoms Associated With Pelvic Floor Dysfunctions in Breast Cancer
NA · 1 location(s) · SERGIO MONTERO NAVARRO · NCT06694519Utero-ovarian Transposition in Patients With Pelvic Malignancies Undergoing Whole Pelvic Radiotherapy
NA · 1 location(s) · University of South Florida · NCT07419490Ketogenic Diet Compliance in Patients Undergoing Radiotherapy for Pelvic Cancers
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05938322A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and U
NA · 1 location(s) · University of Washington · NCT06040762Hypofractionated WPPT With HDR Boost
Phase 2 · 1 location(s) · Abramson Cancer Center at Penn Medicine · NCT06591819Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Uppe
Phase 2 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT05775471Activity Coaching During Pelvic Radiation Therapy
NA · 4 location(s) · Inova Health Care Services · NCT06746428Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers
Phase 2 · 1 location(s) · Mayo Clinic · NCT07087860Postoperative Adjuvant Immunotherapy Combined with Radiotherapy Versus Surgery Alone in Locally Advanced UTUC
Phase N/A · 2 location(s) · Peking University First Hospital · NCT06598761Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unr
Phase 1 · 1 location(s) · Aaron Wolfson · NCT05603910Sacituzumab Govitecan Plus EV in Metastatic UC
Phase 1/Phase 2 · 1 location(s) · Dana-Farber Cancer Institute · NCT04724018Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and
Phase 4 · 1 location(s) · Mayo Clinic · NCT06764095Feasibility of Hyivy Device Post-Radiation for Pelvic Malignancies
NA · 1 location(s) · Hyivy Health Inc · NCT05648253U.S. Prospective Evaluation of EPIONE Device for Percutaneous MSK Procedures
NA · 3 location(s) · Precision IO Group · NCT07325578Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/
Phase N/A · 1 location(s) · University of Washington · NCT01050504Contribution of 3D Modeling in Surgical Management of Pediatric Retroperitoneal and Pelvic Tumors
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06418243EMVI as a Determinant of Metastasis in Colorectal Cancer
Phase N/A · 1 location(s) · Imperial College London · NCT06646341Early Pelvic Floor Physical Therapy for Women Undergoing Pelvic Radiation for Gynecologic Malignancies
NA · 1 location(s) · University of Cincinnati · NCT07447895EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT07410676Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone
Phase N/A · 3 location(s) · Mayo Clinic · NCT05033288Nephron-sparing Treatment of Tislelizumab + Nab-Paclitaxel for Renal Pelvic Cancer
Phase 2 · 1 location(s) · Tianjin Medical University Second Hospital · NCT07233252
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.